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HUNTINGTON'S DISEASE PRESENTING WITH 
SCHIZOPHRENIC SYMPTOMS 




A case which initially presented with schizophrenic symptoms and was being managed as a patient of schizophrenic 
illness with tardive dyskinesia for 12 years, was on careful review of history and examination diagnosed as having 
Huntington's Disease. Clinical and theoretical aspects of Huntington's disease presenting with schizophrenic 
symptoms, and neurological deficits which are seen in schizophrenia are discussed. 
.Huntington's Disease (H D) is a neuro-
degenerative disorder with a prevalence rate of 5 to 10 
per 100,000 world wode. Inherited as an autosomal 
dominant illness it has a fully penetrant gene. In 1983, 
the first genetic marker for H D was found et G8 
linkage, mapped to chromosome 4 which contains the 
gene'for H D (Gusella et al., 1983). 
Clinical expression of H D is usually delayed 
until mid-adulthood. Disordered movements, intellec-
tual decline, dementia and emotional disturbances a*re 
the cardinal features of H D. Intellectual decline or 
dementia is invariably seen, the pattern is usually of a 
sub-cortical dementia (Fisher, 1983). Memory impair-
ment is seen both in recent and remote memory, 
whereas immediate recall and attention are relatively 
spared (Boll et al., 1974).Cerebellar dysfunction, 
seizures and rapidly progressive dementia are common 
with the juvenile onset type than with the adult onset H 
D. 
Insidious change in personality is a common 
prodrome of H D, with antisocial behaviour, somatic 
pre-occupation, conduct disorder and alcoholism 
(Caine and Shoulson, 1983) heralding the onset in 
about one-third of patients. Well defined affective and 
psychotic disturbances are found in about half of 
patients of H D (Folstein etal, 1983). Affective disorder 
appears in 30 - 40 % of patients and often attains the 
severity of major depressive illness. Bipolar affective 
disorders have also been described by Folstein et al. 
(1983). Schizophrenia and atypical psychotic disorders 
are seen in nearly 10% of patients. Symptoms range 
from bizzare somatic to persecutory delusions 
(Mayeux, 1984). None appear to be drug related and 
most respond to appropriate psychotropic medication. 
Patients with H D are at high risk for suicide, partly 
reflecting progressive diasbility and adequate motor 
capacity (Mayeux, 1984). Death usually results in 10 -
25 years after the onset of illness. 
We report here a case of H D presenting with 
schizophrenic symptoms. 
CASE HISTORY 
A 34 year old, married, sikh male presented in 
the psychiatry out-patient clinic with the presenting 
complaints of involuntary abnormal movements of all 
four limbs and trunk, muttering to himself, lack of 
interest in his immediate environment, unexplained 
aggressive outbursts, suspicious of his wife, and lack of 
sleep. The total duration of his illness by now was 12 
years, with three previous hospitalisations and partial 
remissions in symptoms with treatment. He had been 
diagnosed a case of Chronic Schizophrenia (Paranoid 
type) with truncal tardive-dyskinesia. He had been 
treated with various neuroleptics mainly with injectible 
Fluspirfline 10 mg weekly dose. In the recent past he 
was prescribed chlorpromazine, trifluoperazine along 
with trihexy-phenydyi and had also received ECT'S (12 
in about 3 months period) as part of his treatment from 
a psychiatrist in private practice. At the time of present 
visit, he was off all medicines for about 5 days. There 
was a reported deterioration in his condition. 
A work-up on the patient suggested the pos-
sibility of a neurological disorder along with prominent 
psychiatric disturbance. Review of his illness history of 
12 years, starting when he was 22 years old, while in 
Canada revealed that the early features of his illness 
were a change in behaviour, excessive smoking of 
cigarettes along with excessive consumption of alcohol 
(he started consuming alcohol at 15 years of age), inap-
propriate aggressivness with impulsive violent be-
haviour. Within a year of this he had first 
hospitalisation, following a period of continuous heavy 
alcohol consumption. He was treated for 2 months in 
a psychiatric clinic, and continued to be under 
psychiatric care even after his discharge. One year later, 
again, after continuous and excessive alcohol consump-
tion, he was hospitalized for a month. On both oc-
casions he was treated as a case of schizophrenic illness 
(paranoid type) and was also recorded to have 
developed truncal tardive-dyskinesia during the second 
hospitalisation. Thereafter he was on continuous treat-
ment with neuroleptics, and had one more hospitalisa-
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tion in India. There was no abuse of alcohol, not even 
history of alcohol in- take for many years now. 
On examination, his general appearance 
showed neglect of personal hygiene with a poor nutri-
tional status. The mental status examination in this 
withdrawn person was made dificult due to the inability 
to communicate normally with him. He showed inap-
propriate affect and muttering, experienced auditory 
hallucinations (accusatory voice of his wife and his 
in-laws), had experiences of being under the control of 
his wife, and delusional belief that his son was not his 
own child. He also showed clinically elicitable disorien-
tation to time, impaired concentration and retention, 
and impaired recent memory. In addition, he har-
boured hostility towards his father, with inappropriate 
self-directed aggressive acts such as banging his head 
against the wall unmindful of the hurt it caused. He 
lacked initiative and interest in any thing. There was a 
total lack of insight into his illness. He had dyscalculia 
and inability to learn new information. He was inter-
viewed by the clinical psychologist for detailed testing 
for organicity, which was not possible due to lack of 
co-operation from the patient. However he did show 
impairment in time-perception, the time having slowed 
down for him. 
A detailed neurological examination was also 
carried out, which revealed generalised clumsiness, 
choreiform movements of all four limbs, abnormal 
swinging of his trunk (back & forth), and abnormal 
nodding of his head, finger and facial movements giving 
bizarre appearances. He had a dysarthria, a 
supranuclear gaze palsy, with marked slowing of sac-
cadic eye movements and brislc oculocephalic response 
along with bilateral pyramidal and ccrebcller sings and 
ataxic gait. 
His mother had died in this hospital 10 years ago 
as a diagnosed case of Huntington's disorder of 2 years 
standing and his only sister aged 18 years underwent 
treatment for generalized seizures of unknown etiology 
for 14 years, and she died, during a status epilcpticus 
very recently. Father was alive and was both mentally 
and neurologically normal. Family history for 
presence/absence of H D in grand-parents could not be 
confirmed. Patinet's early years of life showed aberrant 
behaviour mostly of antisocial type, with abuse of 
alcohol and drugs, starting at a very early age. He had 
dropped out of school in IXth standard and lived in 
aimless, unproductive life. 
The CT Scan of head showed enlarged lateral 
ventricles with mild cortical atrophy frontally and a 
disproportionate caudate atrophy. The clinical picture 
of chorea, dementia, gross neurological deficits, 
schizophrenic symptoms, aberrant personality pattern, 
with a confirmed diagnosis of H D in mother and 
generalised seizures in sister, strongly supported the 
diagnosis of H D in this patient. The additional diag-
nosis of truncal tardive - dyskinesia was dropped as the 
involuntary choreiform movements were a part of H D. 
He was put on neuroleptics as before, on 
Haloperidol increased to 30 mg/day. Trihexyphenydyl 
4 mg/day was added after about 14 days when he 
developed tremors of hands. He responded to treat-
ment with a marked decrease in the choreic movements 
and schizophrenic symptoms. He continued to main-
tain improvement without a complete recovery till a 
year and a half after his discharge, i.e. his last recorded 
visit to this hospital. 
DISCUSSION 
X his case presenting with clinical pictures of H D. 
and also of schizophrenic illness is being reported here 
because of the diagnostic difficulties arising out of such 
presentations. Surveys have shown that between a third 
and two-thirds of cases of H D. are wrongly disgnosed 
initially <Bolt, 1970; Dewhurst et a!., 1970). Psychiatric 
misdiagnoses are the most common, especially a label 
of schizophrenia or paranoid psychoses. With a diag-
nosis of schizophrenia, the choreiform involuntary 
movements are ascribed to 'Schizophrenic-
mannerisms', or as 'dyskinesia' induced by neuroleptic 
medication. An initial diagnosis of neurosis and affe-
live psychosis are almost invariably corrected, where 
as those of schizophrenia, neurological disorder, or 
dementia of other cause is less likely to be revised 
before the patient's death (Bolt, 1970). However, a 
correct diagnosis of H D which is not a rare disease, is 
of great help for genetic counselling to the patient's 
family. As in this case, the diagnosis is always based on 
the clinical picture, and a positive history of H D in the 
family (Brain, 1977). 
The second question concerns the occurrence of 
schizophrenic symptoms in H D. The cause of per-
sonality changes and psychotic symptoms in H D. is still 
speculative. Dopamine metabolism is implicated in the 
pathogenesis of schizophrenia, but this issue has not 
been raised in H D. although post-mortem studies have 
revealed increased dopamine content (Spokes, 1981) 
and reduced levels of gamma-aminobutyric acid 
(GABA) in the basal ganglia and substantia-nigra of 
brains from patients with H D, when compared to 
brains from neurologically normal persons. An im-
balance between GABA and dopamine in such location 
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feature in H D, atleast as far as the movement disorder 
is concerned (Perry et al., 1973). It is also experienced 
that patients of H D have the most consistent an-
tichoreic effects with dopamine-receptor blacking 
drugs or drugs that deplete pre-synaptic dopamine 
(Shoulson, 1979). while this explains the therapeutic 
response, it still does not clarify anymore the etiological 
heterogeneity of schizophrenic illness. 
Finally, we need to know whether schizophrenia 
has any neurological abnormalities associated with it to 
anable us to differentiate between H D and 
schizophrenia in a better way. H D is almost always 
associated with dementia and varied neurological ab-
normalities, but this is still a point of much debate in 
schizophrenic illness. Patients diagnosed as having 
schizophrenia have been found to have increased 
prevalence of neurological abnormalities, indicating 
localised dysfunction of corticospinal tracts, basal 
ganglia and cerebellum, when compared with hospi-
talized normal volunteers (Woods et al., 1986). Cogni-
tive impairment in schizophrenic patients such as 
under-estimate of their own ages of the present year 
and the duration of their hospital stay, i.e. temporal 
disorientation are associated with a significant increase 
in lateral ventricular size as seen on CT Scan, This is 
unrelated to past physical treatment, but is related to 
the presence of behavioural deterioration and abnor-
mal involuntary movements often described as "tardive 
dyskinesia" and is not always attributed to neuroleptic 
drug medication (Crow et al., 1986). Goldberg et al. 
(1987) have speculated on the idea of presence of 
"dementia of the prefrontal type in schizophrenia", 
whereas changes located in the temporal lobe having 
a degree of selectivity for the left hemisphere have been 
reported by others (Crow et al., 1986). 
Thus H D mis-diagnosed as schizophrenic ill-
ness is understandable, and more research into the 
biochemical and pathogenetic association between 
these two is needed not only to remove the diagnostic 
errors, but also to help identify specific diseases at an 
early stage. 
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